ea0086p247 | Neuroendocrinology and Pituitary | SFEBES2022
T. C. Yu Arthur
, Wernig Florian
, Meeran Karim
, Martin Niamh
, Mendoza Nigel
, Nair Ramesh
, Jones Brynmor
, Gontsarova Anastasia
, Behary Preeshila
Introduction: Prolactinomas are the commonest type of secretory pituitary tumours. In current practice, dopamine agonists (DA) remain the mainstay treatment. However, treating physicians are increasingly aware of DA-associated impulse control disorders (ICD) in their patients. We describe 4 individuals with prolactinomas, who either developed ICD on DA or deemed at high risk, successfully managed surgically with preservation of pituitary function. All decisions for...